Kohinoor Hospital Competitors and Similar CompaniesClear all

Kohinoor Hospital's competitors and similar companies include Grupo Policlinica, Eisai, Enloe Health and Mercy Medical Center.

	Kohinoor Hospital Kohinoor Hospital is a provider of healthcare services.	Grupo Policlinica Grupo Policlinica is a provider of healthcare solutions.	Eisai Eisai (エーザイ株式会社) is a research-based human healthcare company that discovers, develops, packages, and markets pharmaceutical products.	Enloe Health Enloe Health (formerly known as Enloe Medical Center) is a non-profit organization that operates a hospital.	Mercy Medical Center Mercy Medical Center is a healthcare provider.
Founding Date	Founding Date 2009	Founding Date 1969	Founding Date 1941	Founding Date 1965	Founding Date 1874
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare hospitals oncology pharma surgical solutions	Tags Healthcare hospitals oncology surgical solutions	Tags Healthcare drug development hospitals oncology pharma	Tags Healthcare Non-Profit hospitals oncology surgical solutions	Tags Healthcare hospitals oncology surgical solutions women's health
Locations	Locations Mumbai, IN HQ	Locations Eivissa, ES HQ	Locations Tokyo, JP HQ Melbourne, AU Wien, AT Leuven, BE Mississauga, CA see more	Locations Chico, US HQ Chico, US Chico, US Chico, US Chico, US Chico, US see more	Locations Baltimore, US HQ Baltimore, US Baltimore, US Columbia, US Glen Burnie, US Lutherville, US Reisterstown, US
Employees	Employees 210	Employees 201	Employees 11,067	Employees 1,9641% increase	Employees 2,185
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥789.4b (FY, 2025)	Revenue (est.) $998m (FY, 2024)	Revenue (est.) $516.5m (FY, 2020)
Net income	Net income N/A	Net income N/A	Net income ¥48.1b (FY, 2025)	Net income $59.8m (FY, 2024)	Net income $360.4m (FY, 2020)
Operating ⚠
Services Provided	Services Provided N/A	Services Provided N/A	Services Provided N/A	Services Provided 82 (Oct, 2022)	Services Provided 41 (Oct, 2022)